Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
At close: Jan 21, 2026
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $334.65 thousand as of January 23, 2026. Its market cap has increased by 4,227.60% in one year.
Market Cap
334.65K
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
1.80
Stock Price
$0.00
Market Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 334.65K, an increase of 1,134.88%. That is a compound annual growth rate of 29.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 334.65K | - |
| Dec 31, 2025 | 334.65K | 8,556.31% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 628.70K |
| Bio-Path Holdings | 619.22K |
| Regenerative Medical Technology Group | 512.42K |
| Helix BioMedix | 449.42K |
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 370.14K |
| Hemagen Diagnostics | 312.33K |
| THC Farmaceuticals | 310.05K |